Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AVANIR Invites Investors to Webcast of Pacific Growth Equities Life Sciences Growth Conference Presentation.


SAN DIEGO San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay.  -- AVANIR Pharmaceuticals, (AMEX AMEX

See: American Stock Exchange
:AVN AVN Aviation
AVN Avenue
AVN Adult Video News
AVN Avascular Necrosis
AVN Atrioventricular Node
AVN Aviation Model (weather forecast model, now Global Forecast System)
AVN Air Vanuatu (ICAO code) 
) today announced that its presentation at the Pacific Growth Equities Life Sciences Growth Conference will be webcast live through the Company's web site at http://www.avanir.com. Vice President and Chief Financial Officer Gregory P. Hanson will be presenting at 9:30 am Pacific time on June 8th from the conference in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden .

The live webcast will be accessible through AVANIR's corporate website via a link on the lower left side of the homepage. To access the webcast, please log on to AVANIR's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. An archived version of the presentation will be available for 90 days following the conference.

AVANIR Pharmaceuticals is a pharmaceutical company focused on developing and commercializing novel therapeutic products for the treatment of chronic diseases. AVANIR's product candidates address therapeutic markets that include central nervous system and cardiovascular disorders, inflammation, and infectious disease Infectious disease

A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions.
. AVANIR expects to submit the final module of its rolling new drug application to the U.S. Food and Drug Administration for its lead product candidate, Neurodex(TM), in mid-2005. Recently, AVANIR partnered its preclinical research and development program for inflammatory disease Noun 1. inflammatory disease - a disease characterized by inflammation
disease - an impairment of health or a condition of abnormal functioning

NEC, necrotizing enterocolitis - an acute inflammatory disease occurring in the intestines of premature infants;
 with Novartis. The Company's first commercialized product, Abreva(R), is marketed in North America by GlaxoSmithKline Consumer Healthcare and is the leading over-the-counter product for the treatment of cold sores. Further information about AVANIR can be found at www.avanir.com.

The information contained in this press release, including any forward-looking statements contained herein, should be reviewed in conjunction with the company's most recent Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 and other publicly available information regarding the company. Copies of such information are available from the company upon request. Such publicly available information sets forth many risks and uncertainties related to the company's business and technology. Forward-looking statements often contain such words like "estimate," "anticipate," "believe," "plan" or "expect". Final review decisions made by the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 and other regulatory agencies concerning clinical trial results are unpredictable and outside the influence and/or control of the company. The Company disclaims any intent or obligation to update these forward-looking statements.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 3, 2005
Words:359
Previous Article:Canterbury Reports Fiscal 2004 Loss.
Next Article:PortalPlayer, Inc. to Present at Bear Stearns 16th Annual Technology Conference; Presentation Time Has Changed to 10:00 A.M. ET.



Related Articles
Charles River Laboratories Management to Present at June Conferences.
Endologix To Present At Pacific Growth Equities - Life Sciences Growth Conference; Webcast Scheduled June 9 at 5:00 p.m. ET.
Applied Biosystems to Webcast Presentation at Pacific Growth Equities Life Sciences Growth Conference.
Pacific Growth Equities Life Sciences Growth Conference to Webcast Nektar's Presentation.
AVANIR Pharmaceuticals Invites Investors to the Lazard Life Sciences Conference Webcast.
AVANIR Pharmaceuticals Invites Investors to the Bank of America and the UBS Global Life Sciences Conference Webcasts.
AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast.
AVANIR Pharmaceuticals Invites Investors to Its First Quarter Conference Call on Thursday, February 9, 2006.
Natus to Present at the Pacific Growth Equities 2006 Life Sciences Growth Conference; Webcast Available on Company Web Site.
Gilead Sciences to Present at Two Upcoming Investor Conferences.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles